IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia

BACKGROUND: Heparin-induced thrombocytopenia (HIT) complicated by severe thrombocytopenia and thrombosis can pose significant treatment challenges. Use of alternative anticoagulants in this setting may increase bleeding risks, especially in patients who have a protracted disease course. Additional t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Chest
Päätekijät: Padmanabhan, Anand, Jones, Curtis G., Pechauer, Shannon M., Curtis, Brian R., Bougie, Daniel W., Irani, Mehraboon S., Bryant, Barbara J., Alperin, Jack B., Deloughery, Thomas G., Mulvey, Kevin P., Dhakal, Binod, Wen, Renren, Wang, Demin, Aster, Richard H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American College of Chest Physicians 2017
Aiheet:
Antithrombotic Therapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812774/
https://ncbi.nlm.nih.gov/pubmed/28427966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2017.03.050
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia